Skip to content
Forest Global Training Partners
Home Services AI Governance AI Navigators Contact Us
AI Navigators AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. Roche receives FDA Clearance for blood test that assesses…

AI Risks January 31, 2025 · Medical Economics

Roche receives FDA Clearance for blood test that assesses cardiovascularrisk

Medical Economics AI is no longer the realm of speculative science fiction—it's here, and it's moving fast. My bold prediction? By 2026, the majority of front desk …

Read the original at Medical Economics ↗

Topics
Healthcare
Mentions
FDA
Tags
AI Use Case
Tracked via
Google Alert “AI Risks”

Related articles

  • icometrix'sAI-driven MRI solution, icobrain aria receives US FDA clearance for safer ... AI Risks · Nov 16, 2024
  • Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm ... AI Use Cases · Jun 26, 2024
  • AI-driven oculomics assesses HbA1c for cardiovascularrisk- News-Medical AI Risks · Oct 11, 2024
  • Sepsis blood test combined with AI could offer early detection tool - The Guardian AI Risks · Mar 30, 2024
  • Avicenna.AI Receives EU Certification for AI Imaging Products - Pharmaceutical Executive AI Use Cases · Jul 08, 2024
  • Cardano's Future: Bold Prediction byAIModel - Cryptopolitan AI Risks · Dec 25, 2023

AI Navigators is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact